We are live on
!
Find out more
CC
ClearArc Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
(+7.2%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.08M |
| 2 |
SVC
Service Properties Trust
SVC
|
+$1.9M |
| 3 |
PPL
PPL Corp
PPL
|
+$1.79M |
| 4 |
Camden Property Trust
CPT
|
+$1.59M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.55M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.1M |
| 3 |
BP
BP
|
+$798K |
| 4 |
Xerox
XRX
|
+$774K |
| 5 |
AstraZeneca
AZN
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.83% |
| 2 | Technology | 14.13% |
| 3 | Healthcare | 12.38% |
| 4 | Energy | 11.6% |
| 5 | Industrials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Delta Air Lines
DAL
$60.1B
| $660K | 0.15% |
17,044
+212
| +1% | +$8K |
|
|
PXD
177
DELISTED
Pioneer Natural Resource Co.
PXD
| $660K | 0.15% |
2,870
+26
| +0.9% | +$5.37K |
|
|
BHI
178
DELISTED
Baker Hughes
BHI
| $654K | 0.15% |
8,783
+127
| +1% | +$8.84K |
|
179
VF Corp
VFC
$5.89B
| $637K | 0.15% |
10,732
-165
| -2% | -$9.59K |
|
|
SCHW
180
Charles Schwab
SCHW
$187B
| $634K | 0.15% |
23,557
+410
| +2% | +$10.8K |
|
181
Exelon
EXC
$47B
| $631K | 0.15% |
24,238
+454
| +2% | +$11.6K |
|
182
Ecolab
ECL
$79.9B
| $630K | 0.15% |
5,658
-516
| -8% | -$55.3K |
|
|
ALXN
183
DELISTED
Alexion Pharmaceuticals
ALXN
| $623K | 0.14% |
3,988
+71
| +2% | +$11.2K |
|
184
CSX Corp
CSX
$93.1B
| $622K | 0.14% |
60,585
+762
| +1% | +$7.42K |
|
|
RTN
185
DELISTED
Raytheon Company
RTN
| $620K | 0.14% |
6,723
+11
| +0.2% | +$1.07K |
|
|
RDS.B
186
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $613K | 0.14% |
7,045
+321
| +5% | +$26.7K |
|
187
Devon Energy
DVN
$47.3B
| $611K | 0.14% |
7,700
+126
| +2% | +$9.16K |
|
188
Archer Daniels Midland
ADM
$36.9B
| $600K | 0.14% |
13,593
+557
| +4% | +$24.6K |
|
189
Cognizant
CTSH
$26B
| $599K | 0.14% |
12,248
+213
| +2% | +$10.4K |
|
190
WEC Energy
WEC
$35.1B
| $596K | 0.14% |
12,701
+426
| +3% | +$19.8K |
|
191
State Street
STT
$50.7B
| $584K | 0.13% |
8,679
-1,608
| -16% | -$106K |
|
192
PPG Industries
PPG
$26.6B
| $581K | 0.13% |
5,530
+40
| +0.7% | +$3.97K |
|
|
MRSH
193
Marsh
MRSH
$91.5B
| $573K | 0.13% |
11,060
+212
| +2% | +$10.5K |
|
194
Truist Financial
TFC
$64B
| $570K | 0.13% |
14,455
-12,578
| -47% | -$482K |
|
195
Aflac
AFL
$62.6B
| $569K | 0.13% |
18,268
+214
| +1% | +$6.68K |
|
|
NBL
196
DELISTED
Noble Energy, Inc.
NBL
| $561K | 0.13% |
7,243
-385
| -5% | -$28K |
|
197
Analog Devices
ADI
$190B
| $553K | 0.13% |
10,227
-3,382
| -25% | -$179K |
|
198
Applied Materials
AMAT
$428B
| $552K | 0.13% |
24,500
+518
| +2% | +$10.6K |
|
199
American Electric Power
AEP
$68.4B
| $548K | 0.13% |
9,834
+175
| +2% | +$9.23K |
|
200
Cardinal Health
CAH
$55.4B
| $547K | 0.13% |
7,973
+79
| +1% | +$5.38K |
|
Similar funds
BO
GCA
QCM
AEPI
AC
LA
JFM
SHA
ClearArc Capital's Q2 2014 Portfolio in Review
As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
- ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
- ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
- ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
- ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
- ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
- ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.
Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.